NSE filing, NSE: ONYX. Summary written from the filing by ALFA Finder's alert engine.
Onyx Biotec Ltd: key numbers
- Share price
- ₹34.60
- Market cap
- ₹62.74 Cr
- Revenue (annual)
- ₹69.47 Cr
- Net profit (annual)
- ₹-0.21 Cr
- P/E (TTM)
- -292.6×Sector 42.0×
- Promoter holding
- 41.74%
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Onyx Biotec Ltd
All →Onyx Biotec Other Announcement
Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Onyx Biotec Open Offer
Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.
Onyx Biotec Open Offer: ₹17.21 Cr
Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.
- Value
- ₹17.21 Cr
Onyx Biotec Annual General Meeting
Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.
Onyx Biotec Annual General Meeting
Onyx Biotec Limited will hold its 21st Annual General Meeting on September 28, 2026, via video conferencing to transact the company's business.
Onyx Biotec Management Change
Onyx Biotec Limited has announced a change in the designation of Mr. Naresh Kumar from Whole-Time Director to Executive Director, effective September 3, 2026.
Other board meeting date announcements
All →B.D. Industries (Pune) Board Meeting Date
B. D. Industries (Pune) will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results. The agenda items are proposed only and no decision has been taken yet.
Health X Platform Board Meeting Date
Health X Platform will hold a board meeting on 14 November 2026 to approve quarterly results. Trading window stays closed until 48 hours after declaration.
Exato Technologies Board Meeting Date
Board meeting set for November 14, 2026 to approve half-year results and an ESOP scheme. Trading window closed from October 1.
Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Brainbees Solutions Board Meeting Date
Brainbees Solutions will hold a board meeting on November 14, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 16.
Senco Gold Board Meeting Date
Senco Gold schedules a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after declaration.